Results 161 to 170 of about 105,659 (312)
Application of hologram technology combined with 3D printing in transperineal prostate biopsy. [PDF]
Tan X +6 more
europepmc +1 more source
The Application of Telemedicine in Surgery
This figure provides an overview of the content presented in this article. Telemedicine is integrated throughout the entire surgical workflow, with distinct applications across the preoperative, intraoperative, and postoperative phases. These applications are enabled by a suite of supporting technologies, while the associated implementation challenges ...
Yufan Yang +8 more
wiley +1 more source
Prostate Biopsy Once Again Is a Hot Topic in This Issue of the International Brazilian Journal of Urology. [PDF]
Favorito LA.
europepmc +1 more source
Abstract Objective To evaluate how patient circumstances that may influence access to care, including area deprivation index (ADI), distance to care center, and rural/urban status affect stage of presentation for HNSCC. Study Design Retrospective, single‐institution study. Setting Urban, academic tertiary care center. Methods Patients with a history of
Kelly Bridgham +7 more
wiley +1 more source
Consistency of multiparametric MRI-guided transperineal prostate biopsy and Gleason score after radical prostatectomy: A retrospective observational study. [PDF]
Wu Y, Xu L.
europepmc +1 more source
Abstract Recently, we suggested the combination of chemotherapy and P2RX4 inhibition as a promising novel therapeutic approach for P2RX4‐expressing epithelial tumors to prevent paracrine resistance. Here, we aimed to assess whether determining P2RX4 expression status in colorectal and pancreatic cancer patients would allow stratification of potentially
Christoph Steup +12 more
wiley +1 more source
Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET-Targeted Prostate Biopsy for Prostate Cancer Diagnosis. [PDF]
Jiao J +21 more
europepmc +1 more source
[Prostate biopsy: approaches].
BERTACCINI, ALESSANDRO +7 more
openaire +3 more sources
ABSTRACT Background Prostate‐specific antigen (PSA) is a widely used prostate cancer marker; however, its use is limited by its low specificity. Novel biomarkers are being explored to avoid unnecessary biopsies. A new prostate cancer marker, S2,3PSA, became eligible for insurance coverage in February 2024.
Jun Furumido +10 more
wiley +1 more source
ProBot: Robot-Ultrasound Probe for Transrectal and Transperineal Prostate Biopsy. [PDF]
Stoianovici D +8 more
europepmc +1 more source

